PAVmed Funding: How Much Did They Raise & Key Investors

How Much Did PAVmed Raise?
Funding & Key Investors

PAVmed Inc. has solidified its market position through a series of strategic capital infusions, culminating in a recent major strategic investment of $30M. This latest injection of liquidity brings the firm's cumulative financing to $51.2M, underscoring investor confidence in its diversified medical technology portfolio. As a commercial-stage entity, PAVmed continues to leverage these resources to accelerate the deployment of its innovative diagnostic and therapeutic solutions across the global healthcare landscape.

The company's trajectory, marked by a history of debt financing and private equity backing, reflects a disciplined approach to scaling its operations. By securing this latest round, PAVmed is well-positioned to navigate the complexities of the medical device sector while maintaining its commitment to high-growth clinical applications.

What is PAVmed?

PAVmed

Manufacturing

Medical Devices & Equipment

Founded in 2014 and headquartered in New York, PAVmed Inc. operates as a multifaceted medical technology firm with a broad footprint in diagnostics, digital health, and specialized medical devices. The company's product ecosystem is diverse, encompassing disposable infusion pumps, short-term catheters, and advanced tissue ablation technologies. By integrating these critical care tools into clinical workflows, PAVmed addresses significant gaps in vascular access and percutaneous intervention. Its business model is characterized by a focus on commercial-stage execution, transitioning from research and development to widespread market adoption of its proprietary medical hardware.

How much funding has PAVmed raised?

PAVmed has raised a total of $51.1M across 4 funding rounds:

2019

Debt

$14M

2020

Debt

$150K

Other Financing Round

$7M

2026

Private Equity

$30M

Debt (2019): $14M with participation from Maxim Group LLC

Debt (2020): $150K led by PPP

Other Financing Round (2020): $7M, investors not publicly disclosed

Private Equity (2026): $30M, investors not publicly disclosed

Key Investors in PAVmed

Maxim Group LLC

A full-service investment bank providing financial advisory and capital raising services to emerging growth companies.

PPP

Public-Private Partnership

Undisclosed Private Equity

An institutional investor focused on providing growth capital to established commercial-stage enterprises.

What's next for PAVmed?

With the successful closure of this major enterprise-level funding, PAVmed is poised to enter a new phase of operational expansion. The strategic allocation of these funds will likely prioritize the scaling of manufacturing capabilities for its core device portfolio and the intensification of commercialization efforts for its digital health platforms. Furthermore, the company is expected to utilize this capital to bolster its regulatory and clinical trial pipelines, ensuring that its next-generation ablation and vascular access devices meet the evolving demands of modern healthcare providers. As the firm matures, the focus will shift toward achieving sustainable profitability through increased market penetration and the optimization of its supply chain infrastructure.

See full PAVmed company page

See More Financial Insights